Long-term use of ticagrelor in patients with prior myocardial infarction.

By Marc P. Bonaca, Deepak L. Bhatt, Marc Cohen, P. Steg, R. Storey, E. Jensen, G. Magnani, S. Bansilal, M. Fish, K. Im and 15 more. New England Journal of Medicine, 2015

1,709 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/4fb5d7d5653f6d6151ebe989d430b7002a265798

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. P. O'Gara
2. A. Goette
3. M. Mack
4. L. Fleisher

Citations in the corpus

• The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. (2018, background): “Current ACS guidelines recommend DAPT for up to 1 year after the acute event in patients without indication for OAC, while high-risk patients might require an even longer DAPT duration.(318,319) They do, however, also allow for shorter DAPT durations (3–6 months) in high bleeding risk ACS patients.”
• 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2016, methodology): “Recommendations for Duration of DAPT in Patients With SIHD .”